CareToLive RSS
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Spread The Word
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Donations
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
Posts Tagged ‘CBS’
Provenge is approved!
- Provenge has been approved! Thank you to all who helped achieve this important milestone for cancer patients.
LATEST POSTS
- 02/06/2012 - Great Provenge News Released At ASCO
- 11/27/2011 - Care To Live Board Member Ted Girgus Dies of Prostate Cancer
- 09/06/2011 - Care To Live Update on SEC OIG Investigation into April 28, 2009 Dendreon Bear Raid
- 07/13/2011 - 3 Minute Video Explaining Provenge Treatment
- 06/20/2011 - Abigail Alliance Plans FDA PROTEST June 28
- 06/09/2011 - RIP Charles A. Reinwald — Cancer Cure Coalition Founder
- 04/29/2011 - Care To Live Submits Moment of Silence to CMS
- 04/28/2011 - HHS Desperately Needs Transparency Lessons From CMS
- 04/23/2011 - Please Post for Provenge!
- 04/19/2011 - Another Interim Provenge Prostate Cancer Immunotherapy CMS FOIA Response
MOST POPULAR
- Setting the Record Straight
- Provenge Is Approved But The Lies Continue
- Provenge Works & Costs the Same as Chemo & Comments by Bishop
- The Bloodshed, Bogus Threats, Birth Defects, Bashers Cover Letter
- PROVENGE WILL BE COVERED BY MEDICARE
- CareToLive sends a Freedom of Information Request to the Centers for Medicare & Medicaid Services
- ASCO Tells CMS It Should Cover Provenge
- The Centers for Medicare and Medicaid Services are requesting comments.
- Dr. Snuffy Myers Advocates For Provenge Treatment
- Senators Specter and Kerry - CMS Has Some 'Splaining To Do
WHATS GOING ON
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
WE'LL BE BACK
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
PROVENGE MAKING THE ROUNDS
April 27th, 2010 | Posted by CTLAs Care To Live anxiously waits for the FDA to approve Provenge any minute now, media coverage has picked up. More and more people are learning about this exciting prostate cancer treatment about to revolutionize the way cancer is treated.
It started on Sunday with the Seattle Times running a front page story.
http://seattletimes.nwsource.com/html/localnews/2011695773_dendreon25m.html
This article features a picture and story about retired Boeing manager Bob Feutz, and his wife Fran. Bob participated in a Provenge clinical trial in 2007 and shows no signs of relapse. That’s three years and still going strong.
Yesterday CBS’s The Early Show, ABC’s Good Morning America Show and CBS Evening News, all spread the news. Local affiliates also did reports yesterday.
On The Early Show, Harry Smith spoke to Dr. Jennifer Ashton. Dr. Ashton pointed out that Provenge does not have the toxicity of chemo and radiation and that the exciting thing about this vaccine is that many cancer experts look at it as the future in cancer treatment.
On Good Morning America, George Stephanopoulos interviewed Dr. Richard Besser. Dr. Besser said the hope is for other cancers, to use your own immune system to fight cancer. When Mr. Stephanopoulos asked about the price, Dr. Besser said it would run about $50K to $75K per course but additional studies hope to increase effectiveness and decrease the cost.
On CBS Evening News, Dr. Jon Lapook did the report on Provenge for Katie Couric. The footage contained a clip from the big protest Care To Live and others held outside the FDA Headquarters in Rockville, Maryland.
The Mean Vs. The Median
This science lingo has always confused people into thinking that Provenge only prolongs life 4.1 months. Nothing could be further from the truth.
Dr. Lapook interviewed Dr. Philip Kantoff of Dana-Farber Cancer Institute who said, Provenge works and it prolongs survival. When Dr. Lapook finished his report Katie asked him about the cost. She said considering there is only a little over four month survival, is the vaccine really worth it? Dr. Lapook reminded her Provenge was tested on the sickest patients first.
Luke Timmerman recently did a very good article about the pricing of Provenge. Jan Manarite from the Prostate Cancer Research Institute posted a good comment in regards to price:
PRICE - Keep in mind that Provenge will be a series of 3 pheresis treatments, given over about one month. Done. Most oncology treatments go on for months. Some indefinitely. That one unique variable will make the price of Provenge – in the big picture – end up costing less than many other oncology drugs.
You can read Luke’s article here: Continue Reading PROVENGE MAKING THE ROUNDS »
Popularity: 29%
Tags: , ABC, cancer, Care To Live, CareToLive, CBS, Dendreon, Dr. Lapook, Dr. Philip Kantoff, Dr. Richard Besser, FDA, George Stephanopoulos, Katie Couric, Kerry Donahue, Prostate Cancer, provenge, Seattle Times
Posted in The Cause, The Dysfunctional FDA | 4 Comments »